−2.6640EUR
−173.50 MEUR
40.16 MEUR
46.54 M
About MITHRA
Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women's health by offering new choices through innovation with a particular focus on contraception and menopause. It operates through the following segments: Product Sales, Out-Licensing, and Other. The Product Sales segment includes complex therapeutics, estetrol, and the remaining portfolio of generic products. The Out-Licensing segment offers partnership deals. The Other segment is involved in the research and development services rendered to third parties. The company was founded by Jean-Michel Foidart and Fran?ois Fornieri on July 8, 1999 and is headquartered in Liege, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0R91 is 0.2190 EUR — it has decreased by 1.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange MITHRA PHARMACEUTICALS SA NV NPV stocks are traded under the ticker 0R91.
0R91 stock is 1.14% volatile and has beta coefficient of 0.76. Check out the list of the most volatile stocks — is MITHRA PHARMACEUTICALS SA NV NPV there?
Yes, you can track MITHRA PHARMACEUTICALS SA NV NPV financials in yearly and quarterly reports right on TradingView.
0R91 stock has fallen by 2.23% compared to the previous week, the month change is a 21.36% fall, over the last year MITHRA PHARMACEUTICALS SA NV NPV has showed a 92.24% decrease.
0R91 net income for the last quarter is −123.03 M EUR, while the quarter before that showed −50.47 M EUR of net income which accounts for −143.78% change. Track more MITHRA PHARMACEUTICALS SA NV NPV financial stats to get the full picture.
Today MITHRA PHARMACEUTICALS SA NV NPV has the market capitalization of 14.93 M, it has decreased by 4.11% over the last week.
No, 0R91 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0R91 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MITHRA PHARMACEUTICALS SA NV NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MITHRA PHARMACEUTICALS SA NV NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MITHRA PHARMACEUTICALS SA NV NPV stock shows the sell signal. See more of MITHRA PHARMACEUTICALS SA NV NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MITHRA PHARMACEUTICALS SA NV NPV future price: according to them, 0R91 price has a max estimate of 2.80 EUR and a min estimate of 0.10 EUR. Read a more detailed MITHRA PHARMACEUTICALS SA NV NPV forecast: see what analysts think of MITHRA PHARMACEUTICALS SA NV NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MITHRA PHARMACEUTICALS SA NV NPV EBITDA is −57.61 M EUR, and current EBITDA margin is −142.22%. See more stats in MITHRA PHARMACEUTICALS SA NV NPV financial statements.